Baba S, Furuta T, Fujioka M, Goromaru T
J Pharm Sci. 1983 Oct;72(10):1155-8. doi: 10.1002/jps.2600721011.
Analysis of urinary metabolites of orally administered rutin (I) labeled with deuterium [( 2',5',6'-2H]rutin, rutin-d) was carried out by GLC-MS. In rat urine, 3-hydroxyphenylacetic acid (III), 3-methoxy-4-hydroxyphenylacetic acid (IV), 3,4-dihydroxyphenylacetic acid (V), 3,4-dihydroxytoluene (VI), and 3-(m-hydroxyphenyl)propionic acid (VIII) were identified as rutin metabolites and were differentiated from the corresponding endogeneous compounds. Unchanged I and quercetin (II) were not present in the urine. Rutin-d was injected intraperitoneally in rats, administered orally to neomycin-treated rats, and incubated in vitro with the intestinal contents of rats. The experiments suggested the involvement of intestinal microflora in the metabolism of orally administered I.
采用气相色谱 - 质谱联用(GLC - MS)法对口服氘标记的芦丁(I)[(2',5',6'-2H]芦丁,芦丁 - d)的尿液代谢产物进行了分析。在大鼠尿液中,鉴定出3 - 羟基苯乙酸(III)、3 - 甲氧基 - 4 - 羟基苯乙酸(IV)、3,4 - 二羟基苯乙酸(V)、3,4 - 二羟基甲苯(VI)和3 - (间羟基苯基)丙酸(VIII)为芦丁代谢产物,并与相应的内源性化合物区分开来。尿液中未检测到未变化的I和槲皮素(II)。将芦丁 - d腹腔注射到大鼠体内,口服给予新霉素处理的大鼠,并与大鼠肠道内容物进行体外孵育。实验表明肠道微生物群参与了口服I的代谢过程。